AU2003290359A1 - Anti-cancer agents comprising alkb inhibitors and alkylating agents - Google Patents

Anti-cancer agents comprising alkb inhibitors and alkylating agents

Info

Publication number
AU2003290359A1
AU2003290359A1 AU2003290359A AU2003290359A AU2003290359A1 AU 2003290359 A1 AU2003290359 A1 AU 2003290359A1 AU 2003290359 A AU2003290359 A AU 2003290359A AU 2003290359 A AU2003290359 A AU 2003290359A AU 2003290359 A1 AU2003290359 A1 AU 2003290359A1
Authority
AU
Australia
Prior art keywords
agents
alkb
inhibitors
cancer
alkylating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003290359A
Other versions
AU2003290359A8 (en
Inventor
Kirsty Sarah Hewitson
Luke Alexander Mcneill
Imre Schlemminger
Christopher Joseph Schofield
Richard William David Welford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Publication of AU2003290359A8 publication Critical patent/AU2003290359A8/en
Publication of AU2003290359A1 publication Critical patent/AU2003290359A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003290359A 2002-12-30 2003-12-30 Anti-cancer agents comprising alkb inhibitors and alkylating agents Abandoned AU2003290359A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0230292A GB0230292D0 (en) 2002-12-30 2002-12-30 Anti-cancer agents
GB0230292.5 2002-12-30
PCT/GB2003/005689 WO2004058252A2 (en) 2002-12-30 2003-12-30 Anti-cancer agents comprising alkb inhibitors and alkylating agents

Publications (2)

Publication Number Publication Date
AU2003290359A8 AU2003290359A8 (en) 2004-07-22
AU2003290359A1 true AU2003290359A1 (en) 2004-07-22

Family

ID=9950516

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003290359A Abandoned AU2003290359A1 (en) 2002-12-30 2003-12-30 Anti-cancer agents comprising alkb inhibitors and alkylating agents

Country Status (3)

Country Link
AU (1) AU2003290359A1 (en)
GB (1) GB0230292D0 (en)
WO (1) WO2004058252A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0519605D0 (en) 2005-09-26 2005-11-02 Isis Innovation Assay
GB0809262D0 (en) * 2008-05-21 2008-06-25 Isis Innovation Assay

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002074981A2 (en) * 2001-03-21 2002-09-26 Isis Innovation Ltd. Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase

Also Published As

Publication number Publication date
AU2003290359A8 (en) 2004-07-22
WO2004058252A3 (en) 2004-10-14
GB0230292D0 (en) 2003-02-05
WO2004058252A2 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
EG25482A (en) Inhibitors
AU2003202263A1 (en) Roh-kinase inhibitors
HK1087699A1 (en) Gyrase inhibitors and uses thereof
AU2003298514A1 (en) Methods and compositions using cholinesterase inhibitors
EP1535609A4 (en) Nf-kb activation inhibitors
AU2003259749A1 (en) 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
AU2003300832A1 (en) NF-KappaB INHIBITORS
AU2003232848A1 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
AU2003249683A1 (en) Nf-:b inhibitors
AU2003249477A1 (en) Heterobicylcic metalloproteinase inhibitors
AU2003220437A1 (en) Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
AU2003215756A1 (en) Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
AU2003298810A1 (en) NF-kB INHIBITORS AND USES THEREOF
EP1506778A4 (en) TGF-a EXPRESSION INHIBITORS
AU2003258942A1 (en) Imidazolidinedione-derivatives and their use as metalloproteinase inhibitors
AU2003211520A1 (en) Lfa-1 inhibitors and use thereof
AU2003222058A1 (en) Materials and methods for inhibiting wip-1
AUPS301402A0 (en) Improvements in anchors
AUPS282002A0 (en) Metalloproteinase inhibitors
IL163935A0 (en) Plasma carboxypeptidase b inhibitors
EP1499605A4 (en) NF-KappaB INHIBITORS
AU2003290359A1 (en) Anti-cancer agents comprising alkb inhibitors and alkylating agents
AU2003210671A1 (en) Nek2 inhibitors
AU2003267790A8 (en) Lipase inhibitors and uses thereof
IL165935A (en) Vasopeptidase inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase